AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
COLLECTION OF MORE HEMATOPOIETIC PROGENITOR CELLS WITH LARGE-VOLUME LEUKAPHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: DESIKAN KR JAGANNATH S SIEGEL D NELSON J BRACY D BARLOGIE B TRICOT G
Citation: Kr. Desikan et al., COLLECTION OF MORE HEMATOPOIETIC PROGENITOR CELLS WITH LARGE-VOLUME LEUKAPHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA, Leukemia & lymphoma, 28(5-6), 1998, pp. 501-508
COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA
Authors: DESIKAN KR BARLOGIE B JAGANNATH S VESOLE DH SIEGEL D FASSAS A MUNSHI N SINGHAL S MEHTA J TINDLE S NELSON J BRACY D MATTOX S TRICOT G
Citation: Kr. Desikan et al., COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA, Journal of clinical oncology, 16(4), 1998, pp. 1547-1553
LONG-TERM FOLLOW-UP AFTER HIGH-DOSE THERAPY FOR HIGH-RISK MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S NAUCKE S MATTOX S BRACY D CROWLEY J TRICOT G ALEXANIAN R
Citation: B. Barlogie et al., LONG-TERM FOLLOW-UP AFTER HIGH-DOSE THERAPY FOR HIGH-RISK MULTIPLE-MYELOMA, Bone marrow transplantation, 21(11), 1998, pp. 1101-1107
OLIGOCLONAL PROTEIN BANDS AND IG ISOTYPE SWITCHING IN MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE THERAPY AND HEMATOPOIETIC-CELL TRANSPLANTATION
Authors: ZENT CS WILSON CS TRICOT G JAGANNATH S SIEGEL D DESIKAN KR MUNSHI N BRACY D BARLOGIE B BUTCH AW
Citation: Cs. Zent et al., OLIGOCLONAL PROTEIN BANDS AND IG ISOTYPE SWITCHING IN MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE THERAPY AND HEMATOPOIETIC-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3518-3523
UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS
Authors: TRICOT G SAWYER JR JAGANNATH S DESIKAN KR SIEGEL D NAUCKE S MATTOX S BRACY D MUNSHI N BARLOGIE B
Citation: G. Tricot et al., UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS, Journal of clinical oncology, 15(7), 1997, pp. 2659-2666
FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA
Authors: JAGANNATH S VESOLE DH ZHANG M DESIKAN KR COPELAND N JAGANNATH M BRACY D JONES R CROWLEY J TRICOT G BARLOGIE B
Citation: S. Jagannath et al., FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA, Bone marrow transplantation, 20(6), 1997, pp. 445-450
HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT
Authors: MEHTA J TRICOT G JAGANNATH S DESIKAN KR SIEGEL D SINGHAL S MUNSHI N VESOLE D MATTOX S BRACY D BARLOGIE B
Citation: J. Mehta et al., HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT, Bone marrow transplantation, 20(2), 1997, pp. 113-116
PERIPHERAL STEM-CELL MOBILIZATION AND ENGRAFTMENT IN PATIENTS OVER AGE 60
Authors: GUBA SC VESOLE DH JAGANNATH S BRACY D BARLOGIE B TRICOT G
Citation: Sc. Guba et al., PERIPHERAL STEM-CELL MOBILIZATION AND ENGRAFTMENT IN PATIENTS OVER AGE 60, Bone marrow transplantation, 20(1), 1997, pp. 1-3
SUPERIOR OUTCOME WITH MELPHALAN-200 MG M(3) (MEL200) FOR SCHEDULED 2ND-AUTOTRANSPLANT COMPARED MEL+TBI OR CTX FOR MYELOMA (MM) IN PRE-TX-2 PR/
Authors: DESIKAN KR FASSAS A SIEGEL D JAGANNATH S MEHTA J SINGHAL S BRACY D TRICOT G BARLOGIE B
Citation: Kr. Desikan et al., SUPERIOR OUTCOME WITH MELPHALAN-200 MG M(3) (MEL200) FOR SCHEDULED 2ND-AUTOTRANSPLANT COMPARED MEL+TBI OR CTX FOR MYELOMA (MM) IN PRE-TX-2 PR/, Blood, 90(10), 1997, pp. 1016-1016
SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S VESOLE DH NAUCKE S CHESON B MATTOX S BRACY D SALMON S JACOBSON J CROWLEY J TRICOT G
Citation: B. Barlogie et al., SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA, Blood, 89(3), 1997, pp. 789-793
SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY
Authors: TRICOT G ALBERTS DS JOHNSON C ROE DJ DORR RT BRACY D VESOLE DH JAGANNATH S MEYERS R BARLOGIE B
Citation: G. Tricot et al., SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY, Clinical cancer research, 2(6), 1996, pp. 947-952
HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA
Authors: TRICOT G JAGANNATH S VESOLE DH BRACY D DESIKAN KR SIEGEL D BARLOGIE B
Citation: G. Tricot et al., HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA, Leukemia & lymphoma, 22(1-2), 1996, pp. 25-36
AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED
Authors: VESOLE DH TRICOT G JAGANNATH S DESIKAN KR SIEGEL D BRACY D MILLER L CHESON B CROWLEY J BARLOGIE B
Citation: Dh. Vesole et al., AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED, Blood, 88(3), 1996, pp. 838-847
CHANGES IN PULMONARY-FUNCTION TEST (PFT) FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND MELPHALAN IN MULTIPLE-MYELOMA (MM) PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (AT)
Authors: JAZIEH AR BRACY D SPINKS C SIEGEL D DESIKAN KR JAGANNATH S HILLER FC BARLOGIE B TRICOT G
Citation: Ar. Jazieh et al., CHANGES IN PULMONARY-FUNCTION TEST (PFT) FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND MELPHALAN IN MULTIPLE-MYELOMA (MM) PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (AT), Blood, 88(10), 1996, pp. 3752-3752
FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLSUPPORT FOR MULTIPLE-MYELOMA PATIENTS OVER THE AGE OF 70
Authors: SIEGEL DS JAGANNATH S DESIKAN KR TRICOT G BRACY D MADDOX S BARLOGIE B VESOLE DH
Citation: Ds. Siegel et al., FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLSUPPORT FOR MULTIPLE-MYELOMA PATIENTS OVER THE AGE OF 70, Blood, 88(10), 1996, pp. 508-508
SALVAGE TRANSPLANT FOR EARLY RELAPSE (LESS-THAN-OR-EQUAL-TO-1 YEAR) AFTER A SINGLE AUTOTRANSPLANT (AT) ARE EFFECTIVE AND IMPROVE OUTCOME
Authors: TRICOT G JAGANNATH S DESIKAN KR MUNSHI N SIEGEL D BRACY D BARLOGIE B
Citation: G. Tricot et al., SALVAGE TRANSPLANT FOR EARLY RELAPSE (LESS-THAN-OR-EQUAL-TO-1 YEAR) AFTER A SINGLE AUTOTRANSPLANT (AT) ARE EFFECTIVE AND IMPROVE OUTCOME, Blood, 88(10), 1996, pp. 513-513
BOTH TRANSLOCATIONS AND 11 13 ABNORMALITIES HAVE A DOMINANT PROGNOSTIC IMPLICATION AND PREDICT POOR OUTCOME IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) TREATED WITH HIGH-DOSE THERAPY AND AUTOTRANSPLANTS (AT)/
Authors: TRICOT G BARLOGIE B JAGANNATH S DESIKAN KR SIEGEL D BRACY D MATTOX S NAUCKE S MUNSHI N SAWYER J
Citation: G. Tricot et al., BOTH TRANSLOCATIONS AND 11 13 ABNORMALITIES HAVE A DOMINANT PROGNOSTIC IMPLICATION AND PREDICT POOR OUTCOME IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) TREATED WITH HIGH-DOSE THERAPY AND AUTOTRANSPLANTS (AT)/, Blood, 88(10), 1996, pp. 1539-1539
SERUM OLIGOCLONAL PROTEIN BANDS AND IMMUNNOGLOBULIN ISOTYPE SWITCH INPATIENTS (PTS) RECEIVING AUTOTRANSPLANTS (AT) FOR MULTIPLE-MYELOMA (MM)
Authors: ZENT CS TRICOT G JAGANNATH S SIEGEL D DESIKAN KR MUNSHI N BRACY D BARLOGIE B BUTCH AW
Citation: Cs. Zent et al., SERUM OLIGOCLONAL PROTEIN BANDS AND IMMUNNOGLOBULIN ISOTYPE SWITCH INPATIENTS (PTS) RECEIVING AUTOTRANSPLANTS (AT) FOR MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 1563-1563
PERSISTENCE OF MAGNETIC-RESONANCE-IMAGING (MRI) ABNORMALITIES POSTTRANSPLANTATION DOES NOT PREDICT FOR EARLY RELAPSE IN MULTIPLE-MYELOMA (MM) PATIENTS WHO ACHIEVED COMPLETE REMISSION AFTER DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTS
Authors: JAZIEH AR ANTGUACO E BRACY D MATTOX S PETERSON L JAGANNATH S BARLOGIE B DESIKAN KR SIEGEL D TRICOT G
Citation: Ar. Jazieh et al., PERSISTENCE OF MAGNETIC-RESONANCE-IMAGING (MRI) ABNORMALITIES POSTTRANSPLANTATION DOES NOT PREDICT FOR EARLY RELAPSE IN MULTIPLE-MYELOMA (MM) PATIENTS WHO ACHIEVED COMPLETE REMISSION AFTER DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTS, Blood, 88(10), 1996, pp. 1567-1567
DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE AND CISPLATINUM (DCEP), ANEFFECTIVE REGIMEN FOR RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION (AT)
Authors: MUNSHI NC DESIKAN KR JAGANNATH S SIEGEL D BRACY D TRICOT G BARLOGIE B
Citation: Nc. Munshi et al., DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE AND CISPLATINUM (DCEP), ANEFFECTIVE REGIMEN FOR RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION (AT), Blood, 88(10), 1996, pp. 2331-2331
OUTCOME OF RELAPSE AFTER TRANSPLANTATION IN MYELOMA
Authors: SINGHAL S TRICOT G JAGANNATH S MEHTA J SIEGEL D DESIKAN KR MUNSHI N VESOLE D BRACY D BARLOGIE B
Citation: S. Singhal et al., OUTCOME OF RELAPSE AFTER TRANSPLANTATION IN MYELOMA, Blood, 88(10), 1996, pp. 2433-2433
FEASIBILITY AND EFFICACY OF 3RD TRANSPLANT PROCEDURES IN MYELOMA
Authors: SINGHAL S BARLOGIE B JAGANNATH S BRACY D MEHTA J DESIKAN KR SIEGEL D MUNSHI N TRICOT G
Citation: S. Singhal et al., FEASIBILITY AND EFFICACY OF 3RD TRANSPLANT PROCEDURES IN MYELOMA, Blood, 88(10), 1996, pp. 2434-2434
A SINGLE-CENTER, MATCHED-PAIR COMPARISON OF AUTOGRAFTING AND ALLOGRAFTING IN MULTIPLE-MYELOMA
Authors: MEHTA J TRICOT G JAGANNATH S AYERS D SINGHAL S BRACY D SIEGEL D DESIKAN KR MUNSHI N VESOLE D BARLOGIE B
Citation: J. Mehta et al., A SINGLE-CENTER, MATCHED-PAIR COMPARISON OF AUTOGRAFTING AND ALLOGRAFTING IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 2462-2462
POSTTRANSPLANT ENGRAFTMENT KINETICS AND TOXICITIES IN MULTIPLE-MYELOMA (MM) PATIENTS (PTS) ARE COMPARABLE FOLLOWING MOBILIZATION OF PBSC WITH G-CSF WITH OR WITHOUT HIGH-DOSE CYCLOPHOSPHAMIDE (HD CTX)
Authors: DESIKAN KR JAGANNATH S SIEGEL D MUNSHI N BRACY D BARLOGIE B TRICOT G
Citation: Kr. Desikan et al., POSTTRANSPLANT ENGRAFTMENT KINETICS AND TOXICITIES IN MULTIPLE-MYELOMA (MM) PATIENTS (PTS) ARE COMPARABLE FOLLOWING MOBILIZATION OF PBSC WITH G-CSF WITH OR WITHOUT HIGH-DOSE CYCLOPHOSPHAMIDE (HD CTX), Blood, 88(10), 1996, pp. 2703-2703
TOTAL THERAPY (TT) WITH TANDEM AUTOTRANSPLANTS (2-TX) FOR 231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM)
Authors: JAGANNATH S TRICOT G VESOLE D DESIKAN KR MUNSHI N SIEGEL D CROWLEY J BRACY D MATTOX S NAUCKE S BARLOGIE B
Citation: S. Jagannath et al., TOTAL THERAPY (TT) WITH TANDEM AUTOTRANSPLANTS (2-TX) FOR 231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 2728-2728
Risultati: 1-25 | 26-40